Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective Randomized Double-center Study of Nonsteroidal Antinflammatory Drug Lornoxicam in Patients With Acute Coronary Syndrome Without Persistent ST- Segment Elevation

NCT00997750 is registered in ClinicalTrials.gov with Central Clinical Hospital w/Outpatient Health Center of Business Administration for the President of Russian Federation as lead sponsor.

NCT NCT00997750
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00997750 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective Randomized Double-center Study of Nonsteroidal Antinflammatory Drug Lornoxicam in Patients With Acute Coronary Syndrome Without Persistent ST- Segment Elevation
Lead sponsor
Central Clinical Hospital w/Outpatient Health Center of Business Administration for the President of Russian Federation
Phase
Phase 4
Overall status
Completed
Start date
March 31, 2007
Completion date
June 30, 2009
Enrollment
85 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute coronary syndrome